Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:41:08 EDT Wed 08 May 2024
Enter Symbol
or Name
USA
CA



News for U:PRTA from 2023-05-09 to 2024-05-08 - 18 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-08 16:05U:PRTANews ReleaseProthena Reports First Quarter 2024 Financial Results and Business Highlights
2024-05-01 16:05U:PRTANews ReleaseProthena to Report First Quarter 2024 Financial Results on May 8
2024-04-15 16:05U:PRTANews ReleaseProthena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
2024-03-05 16:05U:PRTANews ReleaseProthena to Participate in Upcoming Healthcare Conferences
2024-02-15 16:05U:PRTANews ReleaseProthena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
2024-02-08 16:05U:PRTANews ReleaseProthena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
2024-01-08 08:30U:PRTANews ReleaseProthena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs
2023-11-02 16:05U:PRTANews ReleaseProthena Reports Third Quarter 2023 Financial Results and Business Highlights
2023-10-26 16:05U:PRTANews ReleaseProthena to Report Third Quarter 2023 Financial Results on November 2
2023-08-31 16:05U:PRTANews ReleaseProthena to Participate in Upcoming Healthcare Conferences
2023-08-03 16:05U:PRTANews ReleaseProthena Reports Second Quarter 2023 Financial Results and Business Highlights
2023-07-27 16:05U:PRTANews ReleaseProthena to Report Second Quarter 2023 Financial Results on August 3
2023-07-17 08:35U:PRTANews ReleaseProthena Presents New Research in the Treatment of Alzheimer ¢ € ™s Disease at Alzheimer ¢ € ™s Association International Conference ‚ ® 2023 (AAIC ‚ ®)
2023-07-11 16:05U:PRTANews ReleaseProthena to Present New Data from Alzheimer ¢ € ™s Disease Programs at Alzheimer ¢ € ™s Association International Conference ‚ ® 2023 (AAIC ‚ ®)
2023-07-10 16:10U:PRTANews ReleaseProthena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody
2023-06-27 16:05U:PRTANews ReleaseProthena Announces Phase 3 VITAL Clinical Trial Results Published in Blood Showing Survival Benefit in Patients with Mayo Stage IV AL Amyloidosis Treated with Birtamimab
2023-06-02 16:05U:PRTANews ReleaseProthena to Participate in Jefferies 2023 Healthcare Conference
2023-05-16 16:05U:PRTANews ReleaseProthena Announces Appointment of Billy Dunn, M.D., to its Board of Directors